Featured Research

from universities, journals, and other organizations

Added Benefit Found For Aspirin Use In Patients With Vessel Disease

Date:
March 11, 1998
Source:
American Heart Association
Summary:
When blood vessels malfunction because of excessive fatty buildup, aspirin may prove to be beneficial in making them work correctly again, say researchers in a study published in a recent issue of Circulation: Journal of the American Heart Association.

DALLAS, March 3 -- When blood vessels malfunction because of excessive fatty buildup, aspirin may prove to be beneficial in making them work correctly again, say researchers in a study published in today's Circulation: Journal of the American Heart Association.

Related Articles


When atherosclerosis -- which is caused by fatty deposits clogging the blood vessels -- occurs, the result can be damage to the endothelium that lines the inside of the vessel. When there is damage to the lining -- known as endothelial dysfunction -- the vessel may not contract properly, leading to other potential problems.

In this study, researchers found that when aspirin was given to 14 patients with atherosclerosis and endothelial dysfunction, there was a strong tendency for improved function of the diseased blood vessels. In the five patients who only had risk factors, but no excessive fatty buildup, the improvement was not seen. The presence of fatty deposits in the vessels was associated with the success of the aspirin treatment.

Aspirin blocks the formation of cyclooxygenase-dependent vasoconstrictors, substances released by the vessel that control its constriction and relaxation. The benefit of aspirin on vascular function can be related to blocking the negative effects of these substances and restoring normal function of the vessel.

Aspirin may now provide another way for physicians to fight back against heart disease, according to the researchers, who are based at the National Heart, Lung and Blood Institute in Bethesda, MD. They add that these findings can partly explain why aspirin has beneficial effects on the rate of heart attacks as proven in other studies.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Added Benefit Found For Aspirin Use In Patients With Vessel Disease." ScienceDaily. ScienceDaily, 11 March 1998. <www.sciencedaily.com/releases/1998/03/980311074627.htm>.
American Heart Association. (1998, March 11). Added Benefit Found For Aspirin Use In Patients With Vessel Disease. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/1998/03/980311074627.htm
American Heart Association. "Added Benefit Found For Aspirin Use In Patients With Vessel Disease." ScienceDaily. www.sciencedaily.com/releases/1998/03/980311074627.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins